Evaluation of Surgical Cases of Lung Cancer Admitted in Shiraz Referral Hospitals, Southern Iran in 2009–2022
Cancer Reports · 2025
DOI: 10.1002/cnr2.70108 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cancer Reports, 2025. Verfasst von Sara Dehghani und 7 weiteren Autor:innen. Beteiligte Einrichtung: Thoracic and Vascular Surgery Research Center, Shiraz University of Medical Science, Shiraz, Iran. Hauptthemen laut MEDLINE: Lung Neoplasms, Pneumonectomy. Die Arbeit nennt 68 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Introduction
Globally, lung cancer is one of the most commonly diagnosed cancers and continues to take the lead in cancer‐related mortality rates. This study aims to provide the latest statistics on the clinical, histopathological, and epidemiological features of lung cancer patients who underwent surgical resection in referral hospitals in Southern Iran.
Method
In this retrospective study, records of all patients with operable primary and secondary lung cancer who underwent surgical resection of the lung in Shiraz hospitals, located in Southern Iran from November 2009 to May 2022 were screened. Data on demographic, clinical, surgical, and pathological characteristics were analyzed by SPSS software.
Results
A total of 232 patients with operable lung cancer, including 150 (64.7%) primary cases and 82 (35.3%) secondary cases, underwent 249 operations. The mean age of primary and secondary lung cancer patients was 56.70 ± 13.99 and 45.56 ± 18.88, respectively ( p < 0.001). Males accounted for 54.0% and 58.5% of primary and secondary lung cancer patients, respectively. Adenocarcinoma was the most frequent primary pathology, while sarcomas were the most common metastatic lesions. The predominant presenting symptoms were cough ( n = 75, 75.0%) and dyspnea ( n = 31, 59.7%) in primary and secondary cases, respectively. Involvement of the right lung was more frequent in both groups (65.5% and 53.1% for primary and secondary cases respectively). The most commonly performed surgeries were lobectomy (69.9%) and limited resection (69.8%) for primary and secondary lesions, respectively. Cigarette smoking and extensive resection had a significant association with the in‐hospital mortality rate ( p = 0.012 and 0.009 respectively). The overall in‐hospital mortality rate was 3.6% ( n = 9).
Conclusion
Surgical interventions were mostly performed in men and histopathologic subtypes of primary lung adenocarcinoma, metastatic soft tissue sarcoma, and metastatic colon cancer. Smoking and extensive resection accompany a higher risk of short‐term postoperative mortality.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Thoracic and Vascular Surgery Research Center, Shiraz University of Medical Science, Shiraz, Iran.
- Student Research Committee, Shiraz University of Medical Sciences, Shiraz, Iran.
- Bone Marrow Transplantation Center, Nemazi Hospital, Shiraz University of Medical Sciences, Shiraz, Iran.
- Department of Surgery, Shiraz University of Medical Sciences, Shiraz, Iran.
- Department of Internal Medicine, Shiraz University of Medical Sciences, Shiraz, Iran.
ORCID-Profile: Reza Shahriarirad
Zitieren
APA
Dehghani, S., Rezvani, A., Shahriarirad, R., Rajabian, M. S., Ziaian, B., Fallahi, M. J., Mardani, P., & Amirian, A. (2025). Evaluation of Surgical Cases of Lung Cancer Admitted in Shiraz Referral Hospitals, Southern Iran in 2009–2022. Cancer Reports. https://doi.org/10.1002/cnr2.70108
Vancouver
Dehghani S, Rezvani A, Shahriarirad R, Rajabian MS, Ziaian B, Fallahi MJ, et al. Evaluation of Surgical Cases of Lung Cancer Admitted in Shiraz Referral Hospitals, Southern Iran in 2009–2022. Cancer Reports. 2025. doi:10.1002/cnr2.70108
BibTeX
@article{Dehghani2025,
author = {Dehghani, Sara and Rezvani, Alireza and Shahriarirad, Reza and Rajabian, Mohammad Sadegh and Ziaian, Bizhan and Fallahi, Mohammad Javad and Mardani, Parviz and Amirian, Armin},
title = {Evaluation of Surgical Cases of Lung Cancer Admitted in Shiraz Referral Hospitals, Southern Iran in 2009–2022},
journal = {Cancer Reports},
year = {2025},
doi = {10.1002/cnr2.70108}
}
EUVIMED